Patent · US Active

HIV protease inhibitors

US7807677B2 · kind B2 · utility

2Cited by

2References

63Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Jenny Ekegren · Huddinge, SE
Anders Hallberg · Stockholm, SE
Hans Wallberg · Stuvsta-Snättringe, SE
Bertil Samuelsson · Huddinge, SE
Mahalingam Kannan · Huddinge, SE

Key dates

Filing date	Feb 9, 2006
Grant date	Oct 5, 2010
Priority date	—
Expiry date	Jun 28, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of the formula I:wherein The compounds have utility as HIV-1 protease inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.